MODIFIED CELLS AND METHODS OF THERAPY
US Application 16/513,933
Filed on 2019-07-17
Filed on 2019-07-17
T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3
Mexico
MX/a/2019/009641
Filed on 2019-08-13
MX/a/2019/009641
Filed on 2019-08-13
METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES
US Patent 11,898,207
Filed on 2019-09-19
Filed on 2019-09-19
METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES
Japan
2019-553512
Filed on 2019-09-27
2019-553512
Filed on 2019-09-27
METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES
European Patent
18721882.1
Filed on 2019-09-30
18721882.1
Filed on 2019-09-30
METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES
China
201880022673.3
Filed on 2019-09-29
201880022673.3
Filed on 2019-09-29
METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES
Canada
3057375
Filed on 2018-03-28
3057375
Filed on 2018-03-28
METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES
Australia
2018244371
Filed on 2019-10-03
2018244371
Filed on 2019-10-03
T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3
Australia
2019213329
Filed on 2019-08-06
2019213329
Filed on 2019-08-06
Cell Linkers for Heterotypic Cell Spheroids
Patent Cooperation Treaty
PCT/US2019/041800
Filed on 2019-07-15
PCT/US2019/041800
Filed on 2019-07-15